Atlas Trials

Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris

Clinical trial NCT04134273 · COMPLETED

Trial details

NCT number
NCT04134273
Sponsor
Sun Pharmaceutical Industries, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2019-03-20
Primary completion
2019-09-17
Enrollment
1260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.